Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective

IMPORTANCE: Diabetic foot ulcers (DFUs) and subsequent amputation incur enormous health and economic burdens to patients, health care systems, and societies. As a novel macrophage-regulating drug, ON101 is a breakthrough treatment for DFUs, which demonstrated significant complete wound healing effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Hsuan-Yu, Yang, Chen-Yi, Ou, Huang-Tz, Chen, Shyi-Gen, Chen, Jui-Ching, Ho, Hui-Ju, Kuo, Shihchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856772/
https://www.ncbi.nlm.nih.gov/pubmed/36633847
http://dx.doi.org/10.1001/jamanetworkopen.2022.50639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856772/
https://www.ncbi.nlm.nih.gov/pubmed/36633847
http://dx.doi.org/10.1001/jamanetworkopen.2022.50639

Ejemplares similares